Dashboard
Manage Tickers

CRIS CURIS INC

Nasdaq curis.com


$ 1.48 $ -0.01 (-0.67 %)    

Thursday, 30-Oct-2025 15:59:52 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 634.36 $ 0.00 (0 %)
DIA $ 475.79 $ 0.00 (0 %)
SPY $ 685.38 $ 0.00 (0 %)
TLT $ 90.31 $ 0.00 (0 %)
GLD $ 368.40 $ 0.00 (0 %)
$ 1.49
$ 1.48
$ 1.45 x 125
$ 1.65 x 2,772
-- - --
$ 1.02 - $ 5.00
49,383
na
18.62M
$ 1.52
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-01-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 02-08-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 03-13-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 05-12-2021 03-31-2021 10-Q
19 03-16-2021 12-31-2020 10-K
20 11-10-2020 09-30-2020 10-Q
21 08-04-2020 06-30-2020 10-Q
22 05-12-2020 03-31-2020 10-Q
23 03-19-2020 12-31-2019 10-K
24 11-05-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-14-2019 03-31-2019 10-Q
27 03-26-2019 12-31-2018 10-K
28 11-01-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-03-2018 03-31-2018 10-Q
31 03-08-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-03-2017 06-30-2017 10-Q
34 05-04-2017 03-31-2017 10-Q
35 03-09-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-09-2016 03-31-2016 10-Q
39 02-29-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

on-october-20-2025-curis-received-nasdaq-notice-indicating-that-the-panel-has-granted-the-company-an-exception-until-november-14-2025t-o-regain-compliance-with-the-mvls-requirement
On October 20, 2025, Curis Received Nasdaq...
10/24/2025 20:07:26

As previously disclosed, on August 21, 2025, Curis, Inc. (the "Company") received notice from the Listing Qualification...

curis-q2-eps-068-beats-136-estimate-sales-275m-beat-264m-estimate
Curis Q2 EPS $(0.68) Beats $(1.36) Estimat...
08/05/2025 12:02:01

Curis (NASDAQ:CRIS) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(1.36) by 50 p...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

a-peek-at-curiss-future-earnings
A Peek at Curis's Future Earnings
08/04/2025 21:04:09

curis-announces-7m-registered-direct-offering-and-private-placement-selling-154m-shares-at-2275-each-the-combined-purchase-price-for-1-share-and-the-associated-common-warrant-is-2275-combined-purchase-price-for-1-pre-funded-warrant-and-the-associated-common-warrant-is-2265
Curis Announces $7M Registered Direct Offe...
07/02/2025 12:36:03

Curis, Inc. ("Curis") (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an or...

hc-wainwright--co-assumes-curis-at-buy-announces-price-target-of-17
HC Wainwright & Co. Assumes Curis at Buy, ...
05/19/2025 11:20:09

HC Wainwright & Co. analyst Joseph Pantginis assumes Curis (NASDAQ:CRIS) with a Buy rating and announces Price Target of...

curis-q1-eps-125-misses-087-estimate-sales-238m-miss-275m-estimate
Curis Q1 EPS $(1.25) Misses $(0.87) Estima...
05/06/2025 12:01:59

Core News & Articles
Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

earnings-outlook-for-curis
Earnings Outlook For Curis
05/05/2025 20:02:50

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/14/2025 21:06:19

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
04/02/2025 12:05:45

hc-wainwright--co-maintains-buy-on-curis-lowers-price-target-to-16
HC Wainwright & Co. Maintains Buy on Curis...
03/31/2025 16:29:57

HC Wainwright & Co. analyst Edward White maintains Curis (NASDAQ:CRIS) with a Buy and lowers the price target from $20 t...

curis-says-orphan-drug-designation-for-pcnsl-granted-in-us-and-eu
Curis Says Orphan Drug Designation For PCN...
03/31/2025 12:19:50

earnings-scheduled-for-march-31-2025
Earnings Scheduled For March 31, 2025
03/31/2025 08:32:14

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
01/02/2025 21:05:44

hc-wainwright--co-reiterates-buy-on-curis-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Curi...
12/10/2024 17:20:39

HC Wainwright & Co. analyst Edward White reiterates Curis (NASDAQ:CRIS) with a Buy and maintains $20 price target.

hc-wainwright--co-reiterates-buy-on-curis-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Curi...
11/15/2024 19:27:05

HC Wainwright & Co. analyst Edward White reiterates Curis (NASDAQ:CRIS) with a Buy and maintains $20 price target.

curis-q3-2024-gaap-eps-170-beats-183-estimate-cash-and-cash-equivalents-of-316m-is-expected-to-provide-cash-runway-into-mid-2025
Curis Q3 2024 GAAP EPS $(1.70) Beats $(1.8...
11/14/2024 13:08:13

Curis (NASDAQ:CRIS) reported quarterly losses of $(1.70) per share which beat the analyst consensus estimate of $(1.83) by 7.1 ...

earnings-scheduled-for-november-14-2024
Earnings Scheduled For November 14, 2024
11/14/2024 08:32:28

examining-the-future-curiss-earnings-outlook
Examining the Future: Curis's Earnings Out...
11/13/2024 17:03:42

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION